| pubmed-article:17023033 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:17023033 | lifeskim:mentions | umls-concept:C1140680 | lld:lifeskim |
| pubmed-article:17023033 | lifeskim:mentions | umls-concept:C0033325 | lld:lifeskim |
| pubmed-article:17023033 | lifeskim:mentions | umls-concept:C0013216 | lld:lifeskim |
| pubmed-article:17023033 | lifeskim:mentions | umls-concept:C0040223 | lld:lifeskim |
| pubmed-article:17023033 | lifeskim:mentions | umls-concept:C1521761 | lld:lifeskim |
| pubmed-article:17023033 | pubmed:issue | 1 | lld:pubmed |
| pubmed-article:17023033 | pubmed:dateCreated | 2007-1-15 | lld:pubmed |
| pubmed-article:17023033 | pubmed:abstractText | Clinicians often question when to start chemotherapy after patients undergo surgery for ovarian cancer. A major unproven concern is whether a long postoperative delay reduces the benefits of an extensive procedure and leads to disease progression. Our objectives were to evaluate the correlation between clinical and pathologic variables and to evaluate the effect of the "time to chemotherapy" (TTC) interval on survival. | lld:pubmed |
| pubmed-article:17023033 | pubmed:language | eng | lld:pubmed |
| pubmed-article:17023033 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17023033 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:17023033 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17023033 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17023033 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17023033 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17023033 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:17023033 | pubmed:month | Jan | lld:pubmed |
| pubmed-article:17023033 | pubmed:issn | 0090-8258 | lld:pubmed |
| pubmed-article:17023033 | pubmed:author | pubmed-author:ClibyWilliam... | lld:pubmed |
| pubmed-article:17023033 | pubmed:author | pubmed-author:LongHarry JHJ | lld:pubmed |
| pubmed-article:17023033 | pubmed:author | pubmed-author:PodratzKarl... | lld:pubmed |
| pubmed-article:17023033 | pubmed:author | pubmed-author:AlettiGiovann... | lld:pubmed |
| pubmed-article:17023033 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:17023033 | pubmed:volume | 104 | lld:pubmed |
| pubmed-article:17023033 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:17023033 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:17023033 | pubmed:pagination | 212-6 | lld:pubmed |
| pubmed-article:17023033 | pubmed:meshHeading | pubmed-meshheading:17023033... | lld:pubmed |
| pubmed-article:17023033 | pubmed:meshHeading | pubmed-meshheading:17023033... | lld:pubmed |
| pubmed-article:17023033 | pubmed:meshHeading | pubmed-meshheading:17023033... | lld:pubmed |
| pubmed-article:17023033 | pubmed:meshHeading | pubmed-meshheading:17023033... | lld:pubmed |
| pubmed-article:17023033 | pubmed:meshHeading | pubmed-meshheading:17023033... | lld:pubmed |
| pubmed-article:17023033 | pubmed:meshHeading | pubmed-meshheading:17023033... | lld:pubmed |
| pubmed-article:17023033 | pubmed:meshHeading | pubmed-meshheading:17023033... | lld:pubmed |
| pubmed-article:17023033 | pubmed:meshHeading | pubmed-meshheading:17023033... | lld:pubmed |
| pubmed-article:17023033 | pubmed:meshHeading | pubmed-meshheading:17023033... | lld:pubmed |
| pubmed-article:17023033 | pubmed:meshHeading | pubmed-meshheading:17023033... | lld:pubmed |
| pubmed-article:17023033 | pubmed:meshHeading | pubmed-meshheading:17023033... | lld:pubmed |
| pubmed-article:17023033 | pubmed:meshHeading | pubmed-meshheading:17023033... | lld:pubmed |
| pubmed-article:17023033 | pubmed:meshHeading | pubmed-meshheading:17023033... | lld:pubmed |
| pubmed-article:17023033 | pubmed:meshHeading | pubmed-meshheading:17023033... | lld:pubmed |
| pubmed-article:17023033 | pubmed:meshHeading | pubmed-meshheading:17023033... | lld:pubmed |
| pubmed-article:17023033 | pubmed:meshHeading | pubmed-meshheading:17023033... | lld:pubmed |
| pubmed-article:17023033 | pubmed:year | 2007 | lld:pubmed |
| pubmed-article:17023033 | pubmed:articleTitle | Is time to chemotherapy a determinant of prognosis in advanced-stage ovarian cancer? | lld:pubmed |
| pubmed-article:17023033 | pubmed:affiliation | Division of Gynecologic Surgery, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA. | lld:pubmed |
| pubmed-article:17023033 | pubmed:publicationType | Journal Article | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:17023033 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:17023033 | lld:pubmed |
